Latest News

STAT Plus: Pharmalittle: Oklahoma trims claims against J&J and Teva in opioid suit; House committee poised to vote on drug pricing bills

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is quite modest. We hope to catch up on our reading, take a few naps, hang with our short people, and putter around the castle. And what about you? This is a fine time to enjoy the great outdoors. Perhaps you could begin the annual ritual called spring cleaning. Or make time for someone special. But please, be careful if you encounter any wind turbines. A reliable source says these are bad for your health. Well, whatever you do, have a grand time. But be safe. Enjoy, and see you soon. …

Oklahoma Attorney General Mike Hunter dropped all but one claim against Johnson & Johnson (JNJ) and Teva Pharmaceutical (TEVA) in a lawsuit alleging the drug makers helped fuel the U.S. opioid epidemic, Reuters writes. Hunter will still bring a public nuisance claim against the companies but is dropping five other claims, including that they violated the Oklahoma Medicaid False Claims Act. The move comes ahead of an upcoming May 28 trial, the first in the U.S. to result from roughly 2,000 lawsuits seeking to hold opioid makers responsible for contributing to the epidemic.

Continue to STAT Plus to read the full story…

Source link

Related posts

Janssen annonce l’approbation de l’ERLEADA® (apalutamide) par la Commission européenne pour les patients atteints d’un cancer de la prostate résistant à la castration non métastatique et présentant un risque élevé de métastases


Anatomy of surprise: Scientists discover hidden blood networks that cross through bone


Why Vaping Emergencies May Be Missed


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy